| Q57174334 | 'Evolutionary medicine' perspectives on Alzheimer's Disease: Review and new directions |
| Q48435028 | A novel correlation between the levels of beta-amyloid protein precursor and tau transcripts in the aged human brain |
| Q29615217 | AP-1 in cell proliferation and survival |
| Q37162747 | APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease. |
| Q35833354 | Accumulation of intercellular adhesion molecule-1 in senile plaques in brain tissue of patients with Alzheimer's disease. |
| Q28181660 | Accumulation of the amyloid precursor-like protein APLP2 and reduction of APLP1 in retinoic acid-differentiated human neuroblastoma cells upon curcumin-induced neurite retraction |
| Q34354817 | Activation of C6 glioblastoma cell ceruloplasmin expression by neighboring human brain endothelia-derived interleukins in an in vitro blood-brain barrier model system |
| Q36404963 | Activation of PPARδ prevents endothelial dysfunction induced by overexpression of amyloid-β precursor protein |
| Q37557587 | Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription |
| Q24323117 | Activation of microglia: a neuroinflammatory role for CAP37 |
| Q34651971 | Advances in the cellular and molecular biology of the beta-amyloid protein in Alzheimer's disease |
| Q44684179 | Allele frequencies of +874T --> A single nucleotide polymorphism at the first intron of IFN-gamma gene in Alzheimer's disease patients |
| Q48581384 | Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer's disease brains |
| Q36283653 | Altered processing of Alzheimer amyloid precursor protein in response to neuronal degeneration |
| Q37967694 | Alzheimer's - Looking beyond plaques |
| Q41005386 | Alzheimer's beta-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40. |
| Q34039644 | Alzheimer's disease and disseminated mycoses. |
| Q40650636 | Alzheimer's disease and prion proteins: a meeting made in muscle. |
| Q37905128 | Alzheimer's disease genetics: lessons to improve disease modelling |
| Q33798898 | Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells |
| Q41181063 | Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease |
| Q26769909 | Amyloid precursor protein and amyloid precursor-like protein 2 in cancer |
| Q33646390 | Amyloid precursor protein mediates a tyrosine kinase-dependent activation response in endothelial cells |
| Q42389524 | Amyloid precursor protein mediates monocyte adhesion in AD tissue and apoE(-)/(-) mice |
| Q36135513 | Amyloid-beta in Alzheimer's disease: the horse or the cart? Pathogenic or protective? |
| Q26766934 | Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders |
| Q53208716 | An antibody against the Alzheimer's disease amyloid precursor protein recognizes distinct conformational isoforms. |
| Q38334997 | An region upstream of the gene promoter for the beta-amyloid precursor protein interacts with proteins from nuclear extracts of the human brain and PC12 cells |
| Q90280217 | Analysis of Surface Levels of IL-1 Receptors and Macrophage Scavenger Receptor I in Peripheral Immune Cells of Patients With Alzheimer Disease |
| Q42488752 | Analysis of the 5'-flanking region of the beta-amyloid precursor protein gene that contributes to increased promoter activity in differentiated neuronal cells |
| Q41741254 | Apoptosis, neurotrophic factors and neurodegeneration |
| Q47855094 | Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice |
| Q38119019 | Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease |
| Q42672221 | Bilateral injections of amyloid-beta 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, and time dependent histopathological effects |
| Q34309107 | Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease |
| Q37228055 | CD 4+ T cells in the pathobiology of neurodegenerative disorders |
| Q34119479 | COX-2 and Alzheimer's disease: potential roles in inflammation and neurodegeneration. |
| Q35237138 | Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner |
| Q34224715 | Cerebral microvascular pathology in aging and Alzheimer's disease |
| Q35196326 | Cerebral pattern of pro- and anti-inflammatory cytokines in dementias |
| Q37265547 | Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor |
| Q35827454 | Chronic IL-1β-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration |
| Q44571010 | Chronic glial activation, neurodegeneration, and APP immunoreactive deposits following acute administration of double-stranded RNA. |
| Q42452339 | Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease |
| Q41933458 | Comparative Transcriptomics Highlights the Role of the Activator Protein 1 Transcription Factor in the Host Response to Ebolavirus |
| Q53238730 | Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease. |
| Q28570754 | Copper chelation represses the vascular response to injury |
| Q48587234 | Cyclooxygenase-2 and presenilin-1 gene expression induced by interleukin-1beta and amyloid beta 42 peptide is potentiated by hypoxia in primary human neural cells |
| Q36126508 | Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial |
| Q40860080 | Cytokines in dementia of the Alzheimer's type (DAT): relevance to research and treatment |
| Q34757351 | DNA binding and regulatory effects of transcription factors SP1 and USF at the rat amyloid precursor protein gene promoter |
| Q44466824 | Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice. |
| Q42477274 | Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease |
| Q42445263 | Differential effects of estrogen in the injured forebrain of young adult and reproductive senescent animals. |
| Q37257692 | Differential effects of interleukin-1beta and S100B on amyloid precursor protein in rat retinal neurons |
| Q36304050 | Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice. |
| Q58565150 | Distinct cytokine profiles in human brains resilient to Alzheimer's pathology |
| Q37324120 | Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease |
| Q36691228 | Does Abeta 42 have a function related to blood homeostasis? |
| Q40561527 | Dorothy Russell Memorial Lecture. The molecular pathology of Alzheimer's disease: are we any closer to understanding the neurodegenerative process? |
| Q37113208 | Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis |
| Q38331415 | Drug delivery of antisense molecules to the brain for treatment of Alzheimer's disease and cerebral AIDS. |
| Q55442166 | Effect of Qingxin Kaiqiao Fang on Hippocampus mRNA Expression of the Inflammation-Related Genes IL-1β, GFAP, and Aβ in an Alzheimer's Disease Rat Model. |
| Q28573508 | Effects of sodium ferulate on amyloid-beta-induced MKK3/MKK6-p38 MAPK-Hsp27 signal pathway and apoptosis in rat hippocampus |
| Q37935917 | Emerging roles of pathogens in Alzheimer disease |
| Q48394865 | Enhanced localization of amyloid beta precursor protein in the rat hippocampus following long-term adrenalectomy |
| Q42472311 | Enhancer function and novel DNA binding protein activity in the near upstream betaAPP gene promoter |
| Q37485179 | Epilepsy: neuroinflammation, neurodegeneration, and APOE genotype |
| Q39032252 | Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium |
| Q40862358 | Expression of amyloid precursor protein in human astrocytes in vitro: isoform-specific increases following heat shock |
| Q43640132 | Extracellular-regulated kinase controls beta-amyloid precursor protein mRNA decay |
| Q48682091 | Factors produced by activated macrophages reduce accumulation of Alzheimer's beta-amyloid protein in vascular smooth muscle cells |
| Q34771671 | Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions? |
| Q40974258 | GM1 inhibits amyloid beta-protein-induced cytokine release |
| Q35686013 | Genetic association of TNF-α-308 G/A and -863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of Iran |
| Q33588353 | Genetic risk factors in Alzheimer's disease |
| Q37059452 | Glial cell dysregulation: a new perspective on Alzheimer disease |
| Q37520360 | Glial cytokines in Alzheimer's disease: Review and pathogenic implications |
| Q91925989 | HHV-6A infection induces amyloid-beta expression and activation of microglial cells |
| Q90049912 | Heat-Shock Proteins in Neuroinflammation |
| Q34874591 | High glucose promotes Aβ production by inhibiting APP degradation |
| Q34995070 | Hypoxia signaling to genes: significance in Alzheimer's disease |
| Q40894077 | IL-1beta and ICE mRNA are not altered upon beta-amyloid(25-35) induced neurotoxicity in human neuroblastoma cells |
| Q41271788 | Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene. |
| Q48726516 | Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations |
| Q39186980 | Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks |
| Q36607337 | Impaired regulation of immune responses in cognitive decline and Alzheimer's disease: lessons from genetic association studies |
| Q40580069 | Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production |
| Q41862255 | In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis |
| Q27003841 | Inconsistencies and controversies surrounding the amyloid hypothesis of Alzheimer's disease |
| Q33259586 | Increased gene expression of Alzheimer disease beta-amyloid precursor protein in senescent cultured fibroblasts |
| Q48054926 | Increased gene expression of beta-amyloid precursor protein and its homologues APLP1 and APLP2 in human neuroblastoma cells in response to retinoic acid |
| Q77674221 | Increased gene expression of interleukin-1alpha and interleukin-6 in rat primary glial cells induced by beta-amyloid fragment |
| Q37324183 | Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity |
| Q35792619 | Increased production of inflammatory cytokines in mild cognitive impairment |
| Q28371517 | Increased vulnerability of neuronal cell lines to sodium nitroprusside-mediated toxicity is caused by the decreased level of nitric oxide metabolites |
| Q28138617 | Inflammation and Alzheimer's disease |
| Q35236248 | Inflammation and the pathophysiology of Alzheimer's disease. |
| Q58555818 | Inflammation as a central mechanism in Alzheimer's disease |
| Q37714770 | Inflammation-sleep interface in brain disease: TNF, insulin, orexin |
| Q27500412 | Inflammatory process in Alzheimer's Disease |
| Q34531006 | Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain |
| Q42482367 | Inhibition of the NGF and IL-1beta-induced expression of Alzheimer's amyloid precursor protein by antisense oligonucleotides |
| Q41152803 | Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF/serum ratios of albumin and IgG. |
| Q33941294 | Interleukin-1 and the immunogenetics of Alzheimer disease |
| Q41063844 | Interleukin-1 beta stimulates mitogen-activated protein kinase in U373 astrocytoma cells without the production of lipid second messengers |
| Q37551939 | Interleukin-1 beta targeted therapy for type 2 diabetes |
| Q28216434 | Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease |
| Q34537594 | Interleukin-1 mediates Alzheimer and Lewy body pathologies. |
| Q38976305 | Interleukin-1 stimulates the beta-amyloid precursor protein promoter |
| Q37974876 | Interleukin-1A -889C/T polymorphism and risk of Alzheimer's disease: a meta-analysis based on 32 case-control studies. |
| Q38356337 | Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. |
| Q46683939 | Interleukin-1beta up-regulates expression of neurofilament light in human neuronal cells |
| Q37100241 | Interleukin-1beta: a bridge between inflammation and excitotoxicity? |
| Q35737149 | Interleukin-1β in Central Nervous System Injury and Repair. |
| Q37813015 | Interleukin-1β with learning and memory |
| Q42276602 | Intra-hippocampal transplantation of neural precursor cells with transgenic over-expression of IL-1 receptor antagonist rescues memory and neurogenesis impairments in an Alzheimer's disease model |
| Q40755785 | Intracellular Abeta is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines |
| Q48524421 | Intracerebral inflammation after human brain contusion |
| Q48121615 | Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia |
| Q35476365 | Intrathecal inflammation precedes development of Alzheimer's disease |
| Q37120749 | Is TNF a link between aging-related reproductive endocrine dyscrasia and Alzheimer's disease? |
| Q48262430 | Is there a genetic basis for the deposition of beta-amyloid after fatal head injury? |
| Q39098686 | LPS induces mediators of neuroinflammation, cell proliferation, and GFAP expression in human astrocytoma cells U373MG: the anti-inflammatory and anti-proliferative effect of guggulipid |
| Q39748678 | Members of the AP-1 family, c-Jun and c-Fos, functionally interact with JC virus early regulatory protein large T antigen |
| Q37629098 | Metabolism of Alzheimer beta-amyloid precursor protein: regulation by protein kinase A in intact cells and in a cell-free system |
| Q33897760 | MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons |
| Q40870408 | Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease |
| Q35986371 | Microglia in Alzheimer brain: a neuropathological perspective |
| Q53199651 | Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. |
| Q37324237 | Microglial interleukin-1 alpha expression in human head injury: correlations with neuronal and neuritic beta-amyloid precursor protein expression |
| Q40611391 | Microvascular pathology and vascular basement membrane components in Alzheimer's disease |
| Q34569187 | Modulation of ABCA1 by an LXR agonist reduces β-amyloid levels and improves outcome after traumatic brain injury |
| Q48824418 | Modulation of interleukin-1 and tumor necrosis factor expression by ?-adrenergic agonists in mouse ameboid microglial cells |
| Q44058213 | Modulatory role of cyclooxygenase inhibitors in aging- and scopolamine or lipopolysaccharide-induced cognitive dysfunction in mice |
| Q37223789 | Molecular Biology of Cytokine Effects on Vascular Endothelial Cells |
| Q38082670 | Molecular basis of etiological implications in Alzheimer's disease: focus on neuroinflammation |
| Q57744908 | Molecular mechanisms of glutamate-induced neurodegeneration |
| Q36302045 | Mononuclear phagocytes in the pathogenesis of neurodegenerative diseases |
| Q48552047 | NSAIDS inhibit the IL-1 beta-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2. |
| Q39908636 | Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease |
| Q26738352 | Neural stem/progenitor cells in Alzheimer's disease |
| Q34656208 | Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease. |
| Q34963776 | Neuroinflammation in Alzheimer's disease and prion disease. |
| Q26995483 | Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors |
| Q93379781 | Neuroinflammatory Cytokines Induce Amyloid Beta Neurotoxicity through Modulating Amyloid Precursor Protein Levels/Metabolism |
| Q35815212 | Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis |
| Q34074190 | Neuroinflammatory signaling upregulation in Alzheimer's disease |
| Q53338728 | Neuronal-glial interactions mediated by interleukin-1 enhance neuronal acetylcholinesterase activity and mRNA expression. |
| Q43992276 | Neutrophils CD11b and fibroblasts PGE(2) are elevated in Alzheimer's disease |
| Q37928994 | Oxidative stress and β-amyloid protein in Alzheimer's disease |
| Q87177486 | P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-α in cultured mouse microglia |
| Q42468518 | Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats |
| Q36318080 | Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development |
| Q88868397 | Piperlongumine Improves Lipopolysaccharide-Induced Amyloidogenesis by Suppressing NF-KappaB Pathway |
| Q34570186 | Post-transcriptional regulation of amyloid precursor protein by microRNAs and RNA binding proteins. |
| Q35186181 | Potential Role of Protease Nexin‐2/Amyloid β‐Protein Precursor as a Cerebral Anticoagulanta |
| Q36318415 | Prevalence of Alzheimer plaques in AIDS. |
| Q40569985 | Processing of Alzheimer A beta-amyloid precursor protein: cell biology, regulation, and role in Alzheimer disease |
| Q48487209 | Protein kinase C activation increases release of secreted amyloid precursor protein without decreasing Abeta production in human primary neuron cultures. |
| Q42502724 | Regulation of amyloid precursor protein release by protein kinase C in Swiss 3T3 fibroblasts |
| Q39698258 | Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. |
| Q38075880 | Review: microglia in protein aggregation disorders: friend or foe? |
| Q38183363 | Role of Activated Glia and of Glial Cytokines in Alzheimer's Disease: A Review |
| Q40437121 | Role of interleukin-1 in stress responses. A putative neurotransmitter |
| Q35047977 | Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease |
| Q24301821 | S100A13 mediates the copper-dependent stress-induced release of IL-1α from both human U937 and murine NIH 3T3 cells |
| Q39511870 | Saturated fatty acids activate microglia via Toll-like receptor 4/NF-κB signalling |
| Q36809843 | Seizure-Induced Regulations of Amyloid-β, STEP61, and STEP61 Substrates Involved in Hippocampal Synaptic Plasticity. |
| Q48227989 | Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients |
| Q42448486 | Stimulated release of the beta-amyloid protein of Alzheimer's disease by normal human platelets |
| Q37272880 | Suppression of ischemia-induced fos expression and AP-1 activity by an antisense oligodeoxynucleotide to c-fos mRNA. |
| Q48182620 | Suppression of post-ischemic-induced fos protein expression by an antisense oligonucleotide to c-fos mRNA leads to increased tissue damage |
| Q35813745 | Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology |
| Q36799810 | Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model |
| Q35834240 | Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex |
| Q37954456 | Systemic and central immunity in Alzheimer's disease: therapeutic implications |
| Q40853980 | The C5a complement activation peptide increases IL-1beta and IL-6 release from amyloid-beta primed human monocytes: implications for Alzheimer's disease |
| Q48375362 | The Dorothy Russell Memorial Lecture. The molecular and cellular sequelae of experimental traumatic brain injury: pathogenetic mechanisms |
| Q40795590 | The Impact of MicroRNAs on Brain Aging and Neurodegeneration |
| Q52337767 | The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas. |
| Q40779615 | The amyloid precursor protein in ischemic brain injury and chronic hypoperfusion |
| Q38184783 | The dark sides of amyloid in Alzheimer's disease pathogenesis |
| Q46480774 | The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance. |
| Q26799258 | The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease |
| Q35010710 | The expression of the amyloid precursor protein (APP) is regulated by two GC-elements in the promoter |
| Q34173160 | The functions of the amyloid precursor protein gene. |
| Q34134388 | The immune system and memory consolidation: a role for the cytokine IL-1beta. |
| Q40807293 | The immunopathology of Alzheimer's disease and some related disorders |
| Q33591583 | The neural mechanisms underlying cholinergic cell death within the basal forebrain |
| Q74485778 | The neuroprotective effects of the recombinant interleukin-1 receptor antagonist rhIL-1ra after excitotoxic stimulation with kainic acid and its relationship to the amyloid precursor protein gene |
| Q34013763 | The pervasiveness of interleukin-1 in alzheimer pathogenesis: a role for specific polymorphisms in disease risk |
| Q48826697 | The potential application of cyclo-oxygenase type 2 inhibitors to Alzheimer's disease |
| Q35172428 | The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease |
| Q41624342 | The role of amyloid in the pathogenesis of Alzheimer's disease |
| Q47296419 | The role of astrocytes in amyloid production and Alzheimer's disease |
| Q35237112 | The role of astroglia in neuroprotection |
| Q40687763 | The role of beta-amyloid peptide in Alzheimer's disease |
| Q31032781 | The role of biomarkers in clinical trials for Alzheimer disease |
| Q37095615 | The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective |
| Q37784863 | The roles of TNF in brain dysfunction and disease |
| Q34750643 | The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease |
| Q40422520 | The toxicity in vitro of beta-amyloid protein |
| Q24315790 | The zinc finger protein CTCF binds to the APBbeta domain of the amyloid beta-protein precursor promoter. Evidence for a role in transcriptional activation |
| Q33904501 | Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging |
| Q48559540 | Transcriptional activation and increase in expression of Alzheimer's beta-amyloid precursor protein gene is mediated by TGF-beta in normal human astrocytes |
| Q40915146 | Transfected human B cells: a new model to study the functional and immunostimulatory consequences of APP production |
| Q35854503 | Trisomy 21 and the brain |
| Q26824702 | Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales |
| Q33900383 | Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. |
| Q34763060 | USF binds to the APBα sequence in the promoter of the amyloid β-protein precursor gene |
| Q52033145 | Unchanged levels of interleukins, neopterin, interferon-gamma and tumor necrosis factor-alpha in cerebrospinal fluid of patients with dementia of the Alzheimer type. |
| Q48390009 | Upregulation of amyloid precursor protein gene promoter in rat primary hippocampal neurons by phorbol ester, IL-1 and retinoic acid, but not by reactive oxygen species |
| Q64986754 | Vascular Dysfunction in Alzheimer's Disease: A Prelude to the Pathological Process or a Consequence of It? |
| Q46051651 | Vascular basement membrane pathology and Alzheimer's disease |
| Q37985635 | Viral and inflammatory triggers of neurodegenerative diseases |
| Q41122108 | beta-Amyloid-induced IL-1 beta release from an activated human monocyte cell line is calcium- and G-protein-dependent |
| Q33908462 | p75NTR antagonistic cyclic peptide decreases the size of beta amyloid-induced brain inflammation |